IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock Institutional Trading Activity


IOVANCE BIOTHERAPEUTICS INC (IOVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2018ARK InvestBuy302,197424,820$4,779
Q2 2018ARK InvestBuy57,527122,623$1,570
Q1 2018ARK InvestBuy65,09665,096$1,100

Frequently asked questions about IOVA activity

  • Which institutional owners are buying IOVA?

    Institutional owners buying IOVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in IOVA activity?

    "Buy" means an investor increased their reported position in IOVA compared to the prior reporting period. This reflects growing exposure to IOVANCE BIOTHERAPEUTICS INC (IOVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in IOVA increasing?

    Institutional interest in IOVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.